Literature DB >> 12796222

Progressive structural brain abnormalities and their relationship to clinical outcome: a longitudinal magnetic resonance imaging study early in schizophrenia.

Beng-Choon Ho1, Nancy C Andreasen, Peg Nopoulos, Stephan Arndt, Vincent Magnotta, Michael Flaum.   

Abstract

BACKGROUND: Many studies have shown that structural brain abnormalities in schizophrenia are already present by the time of index evaluation of first-episode patients. However, whether these abnormalities progressively worsen during the subsequent course of the disorder remains unresolved.
METHODS: To study the longitudinal progression of structural brain abnormalities, high-resolution multispectral magnetic resonance images obtained on 73 recent-onset schizophrenic patients and 23 controls were analyzed using state-of-the-art, well-validated, and highly reliable neuroimaging tools. The mean duration between initial and follow-up MRIs was 3 years. Repeated-measures analysis of covariance was carried out to determine (1) whether brain volume changes differed between patients and controls and (2) the significance of regional brain changes on functional outcome in schizophrenia.
RESULTS: We found accelerated enlargement in cortical sulcal cerebrospinal fluid spaces early in the course of schizophrenia. Instead of the usual trajectory of volume enlargement, patients showed progressive reduction in frontal lobe white matter volume. A reciprocal increase in frontal lobe cerebrospinal fluid volume also occurred at a more rapid rate in patients than in controls. In keeping with most of our a priori hypotheses, patients with poor outcome had greater lateral ventricular enlargement over time than patients with good outcome. Progressive decrement in frontal lobe white matter volume and enlargement in frontal lobe cerebrospinal fluid volume were associated with greater negative symptom severity. Reductions in frontal lobe gray and white matter volumes correlated with poorer executive functioning.
CONCLUSIONS: There are ongoing changes in the brains of schizophrenic patients during the initial years after diagnosis despite ongoing antipsychotic drug treatment. These progressive changes seem to be most evident in the frontal lobes and to correlate with functional impairment. Disruptions in neurodevelopment or neural plasticity may act alone or in combination to bring about these progressive brain deficits in schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12796222     DOI: 10.1001/archpsyc.60.6.585

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  154 in total

1.  White matter integrity, language, and childhood onset schizophrenia.

Authors:  Kristi Clark; Katherine L Narr; Joseph O'Neill; Jennifer Levitt; Prabha Siddarth; Owen Phillips; Arthur Toga; Rochelle Caplan
Journal:  Schizophr Res       Date:  2012-03-10       Impact factor: 4.939

2.  Evidence for white matter abnormalities in schizophrenia.

Authors:  Marek Kubicki; Robert W McCarley; Martha E Shenton
Journal:  Curr Opin Psychiatry       Date:  2005-03       Impact factor: 4.741

Review 3.  [Changes in brain structure caused by neuroleptic medication].

Authors:  H Scherk; P Falkai
Journal:  Nervenarzt       Date:  2004-11       Impact factor: 1.214

4.  Longitudinal progression of frontal and temporal lobe changes in schizophrenia.

Authors:  Derin J Cobia; Matthew J Smith; Lei Wang; John G Csernansky
Journal:  Schizophr Res       Date:  2012-05-29       Impact factor: 4.939

5.  Conceptualization and treatment of negative symptoms in schizophrenia.

Authors:  Sonali Sarkar; Kiley Hillner; Dawn I Velligan
Journal:  World J Psychiatry       Date:  2015-12-22

Review 6.  Biomarkers in psychosis: an approach to early identification and individualized treatment.

Authors:  Heline Mirzakhanian; Fiza Singh; Kristin S Cadenhead
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

7.  Progressive deformation of deep brain nuclei and hippocampal-amygdala formation in schizophrenia.

Authors:  Lei Wang; Daniel Mamah; Michael P Harms; Meghana Karnik; Joseph L Price; Mokhtar H Gado; Paul A Thompson; Deanna M Barch; Michael I Miller; John G Csernansky
Journal:  Biol Psychiatry       Date:  2008-09-23       Impact factor: 13.382

8.  BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION.

Authors:  George Bartzokis
Journal:  Adolesc Psychiatry       Date:  2005

9.  Global white matter abnormalities in schizophrenia: a multisite diffusion tensor imaging study.

Authors:  Tonya White; Vincent A Magnotta; H Jeremy Bockholt; Sumner Williams; Stuart Wallace; Stefan Ehrlich; Bryon A Mueller; Beng-Choon Ho; Rex E Jung; Vincent P Clark; John Lauriello; Juan R Bustillo; S Charles Schulz; Randy L Gollub; Nancy C Andreasen; Vince D Calhoun; Kelvin O Lim
Journal:  Schizophr Bull       Date:  2009-09-21       Impact factor: 9.306

Review 10.  Alzheimer's disease as homeostatic responses to age-related myelin breakdown.

Authors:  George Bartzokis
Journal:  Neurobiol Aging       Date:  2009-09-22       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.